BSECompany Update30 Jul 2026 · 30 Jul 2026, 02:29 pm

Post-results conference call invite for the quarter ended June 30, 2026 is enclosed herewith.

Caplin Point Laboratories Ltd · 524742

✦ AI SummaryResults

Caplin Point Laboratories Ltd has announced a post-results conference call invite for the quarter ended June 30, 2026, to discuss the company's financial performance.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Caplin Point Laboratories Ltd - 524742 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Attachments (1)

📄

a99b9871-b4e3-42d7-a682-62f9240a176b.pdf

pdf

Download →
View document text
July 30, 2026 BSE Limited National Stock Exchange of India Ltd Department of Corporate Relationship Department of Corporate Services 1st Floor, New Trade Ring, Rotunda Building Exchange Plaza, 5th Floor, Phiroze Jeejeebhoy Towers C-1, Block G,Bandra Kurla Complex, Dalal Street, Mumbai- 400001 Bandra (E),Mumbai – 400 051 Scrip Code: 524742 S c r i p C o d e : C A P L I P O I N T . Dear Sir / Madam, Sub : Compliance under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 In terms of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby intimate that a post-results conference call with the analyst’s / fund houses/ investors will be held on Wednesday, August 12, 2026, at 4:30 PM. (IST) to discuss the financial performance of the Company for the quarter ended June 30, 2026. A copy of the Conference Call Invitation is enclosed for your reference. Kindly take the same on your records. The schedule of the aforesaid meeting is subject to change due to exigencies on the part of Analyst / Company. Sincerely Yours For Caplin Point Laboratories Limited Venkatram G General Counsel & Company Secretary Membership No. A23989 Encl: A/a You are cordially invited to the Q1 FY27 Earnings Conference Call of Caplin Point Laboratories Limited Wednesday, August 12, 2026 at 04:30 PM IST Represented by: Mr. C.C. Paarthipan Chairman Mr. Vivek Partheeban Vice Chairman Mr. Ashok Partheeban Vice Chairman Dr. Sridhar Ganesan Managing Director Mr. D. Muralidharan Chief Financial Officer Pre-register to avoid the waiting queue, join with DiamondPass link: Registration Link Conference Dial-In Number +91 22 6280 1116 Universal Access +91 22 7115 8017 Hong Kong: 800 964 448 Singapore: 800 101 2045 International Toll Free USA: 1 866 746 2133 UK: 0 808 101 1573 For further information, please contact: Rashmi Shetty Candice Pereira Zain Gulam Hussain Director - Research AVP Research Associate Dolat Capital Market Pvt. Ltd. Dolat Capital Market Pvt. Ltd. Dolat Capital Market Pvt. Ltd. (D) +91 22 40969724 (D) +91 22 61764873 (D) +91 22 40969790 (M) +91 22 8879111413 (M) +91 22 9833458572 (M) +91 22 9892724209 Email: rashmis@dolatcapital.com Email: candicep@dolatcapital.com Email: zain@dolatcapital.com